EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

This adverse event was reported 1246 times

These drugs are most commonly taken by patients reporting EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED:

# Drug Count
0 PEMBROLIZUMAB 241
1 CARBOPLATIN 136
2 NIRAPARIB 128
3 DEXAMETHASONE 108
4 DEXAMETHASONE 1.5 MG 108
5 BEVACIZUMAB 94
6 RIBOCICLIB 90
7 PACLITAXEL 88
8 DURVALUMAB 74
9 PACLITAXEL (AIBUMIN-BOUND) 73
See all common drugs associated with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LOMUSTINE 27 0.0104
1 TAFASITAMAB-CXIX 9 0.0099
2 NIRAPARIB 128 0.0058
3 ENASIDENIB MESYLATE 16 0.0047
4 DURVALUMAB 74 0.0034
5 TREMELIMUMAB 15 0.0034
6 ENFORTUMAB VEDOTIN 22 0.0028
7 RIBOCICLIB 90 0.0028
8 ADO-TRASTUZUMAB EMTANSINE 21 0.0025
9 TEMOZOLOMIDE 49 0.0023
See all drugs enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED